Endoplasmic Reticulum Stress in the Endothelium: A Contribution to Athero-Susceptibility by Stacchiotti, Alessandra et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 2
Endoplasmic Reticulum Stress in the Endothelium:
A Contribution to Athero-Susceptibility
Alessandra Stacchiotti, Gaia Favero and Rita Rezzani
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/53024
1. Introduction
Currently the onset and progression of atherosclerosis have been established as the result of
different cellular and molecular alterations that are not inevitable but rather predictable and
so modifiable, if recognized on time [1,2].
From a morphologic point of view the vascular wall (common to each artery, vein or capilla‐
ry of blood and lymphatic circulation) is made by three layers or tunicae: the tunica intima-
starting from the inner and containing the endothelium, directly facing blood; the tunica
media-with longitudinally oriented layers of smooth muscle cells connected by elastic and
collagen fibers, that change the thickness according to the vascular type and function; and
the tunica adventitia- the most external layer, containing vasa vasorum, necessary to maintain
high metabolic requirements in larger vessels and the source of endothelial progenitors in
neovasculogenesis [3-5].
However in this complex and specialized architecture, the endothelium layer certainly rep‐
resents the first sensor of hemodynamic stress [6] and the favorite target for atherogenic fac‐
tors, like circulating inflammatory molecules, macrophages, lipoproteins (LDLs) and many
drugs [7].
Therefore in this scenario it is necessary to update the knowledge on the endothelium,
which is the main player in the initial step of atherogenesis, and its involvement in a pivotal
biological mechanism, called endoplasmic reticulum (ER) stress, associated to cardiovascu‐
lar damage and invalidating pathologies such as stroke, cardiac ischemia, chronic renal fail‐
ure, macular degeneration and obesity [8-11].
In particular we elucidate here the importance of the ER stress in the artery wall, because it
very recently has emerged as a novel event able to promote athero-susceptibility and hyper‐
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tension both in animal models and in clinical patients [11,12]. Remarkably this event is early
detectable in the endothelial cells [13], sometimes concurrent with other well-known athero‐
genic processes, like inflammation, oxidative damage and endothelial cell death.
Nevertheless considering the focal distribution of plaques and their cumulative progression
during the whole lifespan [14], it is mandatory to consider the role of ER stress signaling in
the circulatory bed, in order to maintain the proper ER function, so preventing or reducing
the progression into irreversible cardiovascular dysfunctions, such as atherosclerosis, hyper‐
tension and ischemic heart disease [15-17].
We firmly believe that focusing integrated basic and applied research on ER stress in the ar‐
tery tree and in the heart might open new avenues in the treatment and management of in‐
validating cardiovascular complications [18,19].
2. The endothelium and the endoplasmic reticulum homeostasis
According to the most accredited theory that indicates inflammation as the first pathogenic
mechanism of atherosclerosis, the endothelium is really the crucial target of circulating mol‐
ecules or cells and constitutes the main entrance for LDL during the initial step of asympto‐
matic artery wall changes that end into plaques or atheromata and their dramatic clinical
evolution [20-23].
Recent studies have outlined that in atherosusceptible sites in the artery tree, endothelial
cells acquire a proinflammatory phenotype which is permissive in the plaque development
by expressing pro-inflammatory sensors such as Toll-like receptors (TLRs), that in turn at‐
tract leukocytes adhesion in the intima layer. Mainly TLR 2 and TLR4 are active in mouse in
the progression of atherosclerosis and their signals stimulate a downstream adaptor mole‐
cule, called Toll/IL-1 receptor domain-related adaptor protein that induces interferon or
TRIF. Indeed also in human vascular tree, by immunostaining and mRNA survey TLR2 and
TLR4 have been well characterized in selected sites, including the aorta, subclavia, carotid,
mesenteric, iliac and temporal arteries [24].
Nevertheless an important concept to remind here is that the relationship between the vas‐
cular endothelium and the blood is not only “passive” in receiving inflammatory or meta‐
bolic stimuli, but instead “active”, with pleiotropic activities like the secretion of regulatory
factors for cholesterol and lipid homeostasis, platelets recruitment, and the adaptation to lo‐
cal changes of blood flow and pressure [25,26].
Moreover the artery wall, in particular in healthy resistance arteries, is not a static but a dy‐
namic and plastic structure, able to remodel its diameter and structure, adapting to rapid
changes in the systemic pressure [27].
Indeed also artery geometry directly influences the athero-susceptibility and the distribution
of mechanical forces associated to blood flux, that impair the endothelium [25,28,29].
In particular during unstable hemodynamic flux and changes in blood direction, mainly in
arterial branches and bifurcations, it is particularly evident the heterogeneity of endothelial
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phenotypes that change their common flat shape and assume a polygonal morphology to‐
gether with a different turnover. These events are linked to the susceptibility of a specific
vessel to develop atherosclerosis and to the onset of valve calcification in the heart [30-32].
So endothelial dysfunctions may have serious consequences and a direct impact on the en‐
dothelial cells’ role and activities, mainly on the resistance to dangerous stimuli that pro‐
mote the onset of pro-atherogenic vascular damage recently reviewed by [33].
Indeed they involve different structural and functional aspects of the endothelium, that is
classified as a monocellular squamous type of epithelium [34], lining human vascular and
lymphatic tree, poorly detectable by traditional light microscopy but well characterized by
electron microscopy and related techniques [35-37].
Nevertheless the real consideration of the endothelium by physicians has begun about 50
years ago, but only in the last decade, it has obtained more importance in the cardiovascular
community, with the rediscovery of Weibel-Palade bodies and caveole signals, the role of
transcytosis mechanism, and the active participation into vascular permeability [38-40].
Among most critical structural changes linked to endothelial dysfunctions, there are the reduc‐
tion of glycocalix, which is the external component necessary to react against toxic apoB LDL,
and the over-development of fundamental organelles like Golgi complex and the ER [41,42].
Remarkably the ER signaling in the vascular wall is the main topic of this chapter, because
much more attention must be given to ER homeostasis in atheroprone sites in the artery tree,
resulting from a chronic adaptive reaction to flow disturbance, concurrent with oxidative
damage and inflammation [43,44].
Abnormal ER activity has been recently reported in coronary arteries during altered he‐
modynamic changes, diagnosed by genetic techniques as an abnormal transcription of se‐
lected  genes;  while,  in  contrast,  the  transcriptional  activity  is  lacking  in  more  resistant
arterial beds [45,46].
Remarkably it must be pointed out that, in mammalian epithelial cells, the ER is commonly
depicted by ultrastructural analysis as a perinuclear network of tubules and membranes,
and by tomography as a dynamic assembly of tridimensional stacks associated to mitochon‐
dria [47-49].
Moreover it is well-known that the ER has different specialization and structure, called
rough or smooth, if associated or not to ribosomes in the same cell, but in specialized cardiac
and smooth muscle cells in the vascular wall it is called the sarcoplasmic reticulum [50,51].
Anyway, this dynamic organelle represents the elective site where nascent polypeptide
chains are gradually converted in a stable tertiary structure, that is associated to a specific
protein [52].
Among the main ER functions have been comprised the folding of neo-synthesized secreto‐
ry and trans-membrane proteins, the regulation of calcium balance and the synthesis of lip‐
ids, like steroids and cholesterol [53].
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If one of these activities fails, the ER efficiency is lost and aberrant unfolded proteins accu‐
mulate within the ER membranes, causing the “ER stress”. This condition has been defined
as “ any perturbation that compromises the protein folding functionality” in the organelle
and implies an adaptive response to restore correct ER homeostasis [54,55].
So it has become clear that each perturbation in the ER balance interferes with folding process
of different proteins, that are devoid of their intrinsic function, so unable to properly work in
the cells and often degraded by a process called ER associated degradation (ERAD) [56-58].
In mammalian cells, disrupted ER homeostasis can be restored within short or long time ac‐
cording to the type of stimulus, if acute and transient or chronic and prolonged.
It is accepted that endothelial cells may tolerate acute stressors that last short time, such as
circulatory ischemia or hypoxia, calcium and nutrient deprivation, adapting themselves to
clear dysfunctional proteins. In doing this activity, they use a rapid process that involves a
transient intracellular signaling from the ER to the nuclear transcription mechanism of
genes, called “unfolded protein response” or UPR [59-62]. Indeed UPR is able to rectify and
limit the cellular damage induced by metabolic, genetic, environmental factors, enhancing
cell survival, but strictly related to the duration of the stress. On the contrary, if the stressful
stimuli are severe or last for a long time, like the majority of chronic inflammatory and he‐
modynamic factors in atherogenesis, UPR is unable to resolve persistent ER stress so leading
to endothelial cell death, generally by apoptosis (Figure 1).
Figure 1. ER stress balance – Schematic representation of ER homeostasis: on the left, adaptive responses to acute
stress that lead to recovery and on the right, reactions to chronic vascular stress that lead to apoptosis. NF-kB-Nuclear
Factor k-B; ERAD-ER-associated degradation; CHOP- C/EBP homologous protein; JNK- c JUN NH2-terminal kinase.
Adapted by [63].
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3. ER stress and UPR pathways in cardiovascular diseases
Given the vital role of fundamental UPR to augment the protein folding in the ER and to
reduce the pool of misfolded products, it is clear that this organelle represents an efficient
checkpoint for quality control of secretory proteins that may migrate to other organelles
and/or to the plasma membrane to be secreted. Indeed UPR works also in collaboration with
the Golgi apparatus and plasma membrane, and only correctly-assembled molecules are
driven to their final destination. Therefore the kinetic and the amplitude of UPR are emerg‐
ing as key events for combine a stress response in specific cell types to their final fate and
eventually death [64].
In the heart, for example, the UPR pathway produces several proteins, that ameliorate the
ER ability to cope with stress, by three separate mechanisms: 1) translational attenuation,
that avoids further deposition of abnormal proteins in the ER; 2) transcriptional activation of
genes for chaperones and related proteins [65]; 3) activation of a process to hamper the fur‐
ther deposition of dysfunctional proteins called ERAD [11].
Indeed to start the quality control work in the ER factory, it is crucial that about one-third of
novel proteins are translocated there, because they acquire the specific configuration and as‐
sembling with the assistance of ER chaperones, then further change by post-translational
modifications, like disulphide bonds or glycosylation performed by specialized enzymes
[66,67].
Remarkably unlike the cytosol, where the abnormal accumulation of proteins is handled by
different families of chaperones, belonging to heat shock protein (HSP) 20 and HSP70 fami‐
lies, called HSP25/27 and HSP70 [68,69], in the ER environment the UPR mechanism is sus‐
tained by specific resident chaperones, glucose-regulated protein (GRP) GRP78 /Bip, GRP94
and by lectin chaperones calnexin, calreticulin and calmegin [70,71].
In eukaryotic cells GRP78, a trans-membrane protein, is called “the master regulator” of ER
stress response and usually works by binding to nascent polypeptides to ensure their proper
secondary structure. In unstressed conditions, GRP78 is usually associated to three different
UPR-sensors and renders them inactive through the direct interaction with their N-terminus
[72]. In contrast, when unfolded proteins accumulate in the ER, GRP78 dissociates from
three UPR-sensing elements, and allows their oligomerization and activation, so ensuring
the start of the UPR cascade.
Currently, it is established that GRP78 is induced by chemical and inflammatory atherogen‐
ic factors, further associated to ER stress signaling, such as excess cholesterol, oxidized phos‐
pholipids, peroxynitrite, homocysteine [73,74]. In a recent in vitro model, that simulates
human arterial shear stress waveforms, GRP78 was over-expressed in the endothelial cells
as a compensatory effect before lesion development [75]. The mechanisms by which GRP78
increased were dependent on upstream alpha 2-beta1integrin linked to p38 activity localized
to focal adhesion in the endothelial cells upon long-term shear stress [76].
Remarkably in the above study it was further demonstrated that inflammatory cytokines as‐
sociated to atheroprone environment, had no effect on GRP78 expression in the endothelial
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cells. So it is plausible that hemodynamic flow might be the earliest ER stressor and GRP78
inducer in an atheroprone environment.
Moreover the conservative pro-survival role of GRP78 is outlined also in vivo, considering
that GRP78-deficient mice are embryonic lethal and present increased apoptosis [77].
The canonical UPR starting signals include three distinct pathways: the inositol-requiring
kinase 1 (IRE1), the transcriptional factor activating transcription factor 6 (ATF6) and the
protein kinase-like ER kinase (PERK) [15] (Figure 2).
Figure 2. Canonical UPR pathways. IRE1- inositol-requiring kinase 1; ATF6- ATF4- activating transcription factors 6 or
4; XBP1- x-box binding protein 1; eIF2alpha- initiation factor 2 alpha; ERAD- ER-associated protein degradation path‐
way; GRP78- glucose-regulated protein; PERK- protein kinase-like ER kinase; CHOP- C/EBP homologous protein. Modi‐
fied from [15,78].
This last enzyme is able to phosphorylate the translation initiation factor 2 alpha (eIF2alpha)
after ER stress then reduces the further protein load on the ER by blocking mRNA transla‐
tion. In contrast, there are some mRNAs that require eIF2 alpha autophosphorylation for
their translation, including the transcriptional factor ATF4, that is directly involved in the
nuclear activation of UPR-related genes. Furthermore eIF2 alpha influences, by endonu‐
clease activity, the splicing of another transcriptional factor, called X-box binding protein 1
(XBP1), that regulates the transcription of UPR-related genes, although in the heart its func‐
tion is largely unknown [79].
ATF6 is another crucial transcriptional factor that, moving from the Golgi complex, becomes
activated and able to interact with XBP1 target genes for the synthesis of molecular chaper‐
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ones and also for enzymes involved in the ER-associated protein degradation pathway
(ERAD). The ERAD mechanism mediates the translocation of unfolded proteins from the ER
into the cytosol where they are degraded by the ubiquitin-proteasome system and so allevi‐
ates the ER over-crowding [58].
Interestingly, a novel gene, called derlin-3, as a component of the ERAD induced by ATF6,
was recently discovered in the mouse heart, and derlin-3 over-expression was able to protect
cardiomyocytes from ischemia-induced apoptosis in vitro [80].
Besides ER chaperones involvement, dysfunctional proteins may be degraded directly in the
ER in a chaperone-independent manner, by a specialized protease system called the ubiqui‐
tin-proteasome, that works independently or in synergy with the UPR. According to recent
clinical and experimental studies, atherosclerosis may be considered also as a “protein-qual‐
ity disease” and the proteasome works at early phases of the disease, especially in both the
coronary and carotid arteries, as a compensatory reaction to prevent complete protein dys‐
function [81].
It is currently accepted that in mammalians the necessity to remove aberrant proteins that
engulfed the ER environment is based upon three main ER activities: 1) the transient UPR
associated to resident chaperones, 2) the ubiquitin-proteasome system and 3) the prolonged
UPR linked to autophagy [82].
In particular through this last process, properly called macro-autophagy, abnormal cyto‐
plasmic contents or organelles engulfed in autophagosomes, upon fusion with lysosomes,
are degraded.
Evidence is emerging that the ER provides membrane for autophagosome formation and
that autophagy is crucial for ER homeostasis due to its ability to remove unwanted or dam‐
aged organelles like abnormal mitochondria by mitophagy [83]. Moreover the ER contrib‐
utes also lipids and specific proteins, such as beclin-1, to initiate autophagosome formation
very close to itself. This physical proximity probably reflects a functional dependence be‐
tween ER and autophagy process, that in the endothelial cells often occurs in response to
reactive oxygen species (ROS) by circuits localized to the ER surface [84]. However in divid‐
ing cells with high turnover, autophagy may not be so relevant, but in long-lived cells like
smooth muscle cells and cardiomyocytes, it is critical to maintain optimal cellular function.
Remarkably autophagy is a suitable mechanism to eliminate abnormal proteins and organ‐
elles, during fast and relatively mild ER stress conditions, but if the ER stress is severe, this
mechanism is overwhelmed.
Anyway, many studies suggest that autophagy is activated in the heart and vascular tree as
a defensive mechanism for survival during myocardial ischemia/reperfusion and in athero‐
sclerosis [85,86].
If autophagy may be considered as a safeguard that protects vascular wall from rupture-prone
lesions, autophagy up-regulation by recent pharmacologic modulators has been proven to be
effective in short-term experimental studies on knockout atherosclerotic mice [87]. Moreover
autophagy is directly involved in the acute setting of cardiac diseases by providing metabolic
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substrates for producing energy and thiol repairing, so the regulation of the autophagic machi‐
nery may offer promising therapeutic opportunities to treat ischemia/reperfusion damage and
heart hypertrophy [88,89]. Recently this interesting eventuality has been also demonstrated in
experimental studies in genetic murine models, notably beclin 1(+/-) and Atg5 deficient mice,
even if its application in clinical trials is still an hypothesis [90].
In this scenario it is intriguing the proposed role of macrophages, able to remove apoptotic
cell debris in the advanced atherosclerotic plaque by a mechanism called efferocytosis. It is
well-known the active role of these cells in the inflammatory cascade inside the vascular
wall, where they enter as adherent monocytes then become macrophages and foam cells, ac‐
cording to the progression of atherosclerosis [91]. The efferocytosis process seems necessary
to limit atherosclerosis, because only a selective fully-operative efferocytosis retards the pro‐
gression of this inflammatory disease [92-94].
The apolipoprotein E (ApoE) family comprises crucial lipoproteins present in the blood to
transport the cholesterol and also to modulate several metabolic diseases like atherosclerosis
and Alzheimer’s [95]. The human ApoE gene is composed by different isoforms with different
metabolic properties and the most studied are apoE3 that is protective and apoE4 that, in con‐
trast, accelerates atherosclerosis and coronary damage. A recent study demonstrated that peri‐
toneal macrophages isolated from ApoE4 mice were defective in the efferocytosis mechanism
and if stimulated by inflammatory molecules, such as oxidized lipoproteins (ox-LDLs), were
sensitive to apoptosis throughout the abnormal intensification of ER stress pathway [96]. How‐
ever the above condition was greatly ameliorated by chemical stimulation of ER signaling, that
reduced inflammation linked to apoE4, and balanced ER stress response.
Anyway if the UPR involvement in pathological complications has been largely outlined, it
is important to remind that this signaling is commonly evoked during the heart morphogen‐
esis and in healthy physiological conditions [97].
Really the strict association between the UPR signaling and pathology has been reported
since about 20 years ago, in different pioneering papers [98,99] that discussed the relation‐
ship between dysfunctional ER and proteotoxicity, and its direct role in neurodegenerative
conditions characterized by abnormal protein deposition, like Parkinson’s and Alzheimer’s
diseases.
Seminal studies have then elucidated the crucial role of the disruption of the regular ER ac‐
tivity in several metabolic disorders like obesity, diabetes insipidus up to neurodegenerative
diseases like Creuzfeld-Jacob, Hungtington’s, Parkinson’s [9,100]. Moreover this mechanism
has been actually involved in the pathogenesis of chronic disorders, including cancer, liver
diseases, heart failure and in particular atherosclerosis [101,102].
Interestingly ER sensing may contribute to atherogenic damage by four ways: 1) by connect‐
ing lipid metabolism and UPR; 2) by promoting abnormal glucose metabolism and insulin
activation that serve as a bridge-mechanism between metabolic dysfunctions and atheroscle‐
rosis; 3) by driving macrophages cell death after cholesterol loading; 4) by controlling auto‐
immunity based on the processing and presentation of MHC-1 associated peptides.
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Currently there is ample evidence of the involvement of the immune system in the patho‐
genesis of atherosclerosis and ER stress-driven autoimmunity may represent a novel contri‐
buting factor in the progression of the disease [103,104].
4. ER stress induced-cell death in the vascular wall
A growing body of evidence indicates that prolonged ER stress, due to the persistent accu‐
mulation in the ER of misfolded proteins beyond the ability of transient UPR, causes cell
death in the vascular wall and may contribute to the pathogenesis of atherosclerosis and
other cardiovascular disorders, such as cardiac hypertrophy, and acute coronary syndrome
[78,105-107].
Intriguingly, the three arms of UPR act together to resolve the prolonged ER stress but if
they fail to reduce the amount of unfolded or misfolded proteins, an ER-driven pro-apoptot‐
ic signal starts.
The most common apoptosis-triggering molecule associated to UPR signaling is called
C/EBP homologous protein, or CHOP, known also as GADD153 [108].
In the endothelial cells, different atherosclerotic-relevant UPR inducers have been identified
in many in vitro and in vivo studies. In particular, the strict association between ER stress
marker GRP78 and CHOP has been reported in patients and in coronary artery samples,
mainly in thin-wall or ruptured plaques associated with unstable angina respect to stable
plaques. Evident localization of two ER-stress signals was further correlated to mRNA ex‐
pression by in situ hybridization in thin-walled plaques and results indicated a positive rela‐
tionship between these markers and plaque vulnerability in human coronary arteries [109].
Among murine models, many studies have been performed in apolipoprotein E deficient mice
(ApoE-/-), fed a standard chow diet that developed atherosclerosis during the life-span up to ne‐
crotic plaques [110]. In this murine model, ER stress markers such as GRP78 and CHOP are up-
regulated in macrophages at all stages of lesion development in the aortic root [111]. However
it is important to remark that in the aorta of ApoE-/- mice at 9 weeks of age, corresponding to
early atherosclerotic phase, no apoptosis was detected, but this event occurred in macrophages
and foam cells in advanced lesions at 23 weeks of age. Remarkably strong GRP78-immunos‐
taining was also localized in the fibrous cap surface in hyperhomocysteinemic ApoE-/- [112].
Furthermore in transgenic CHOP-deficient mice less macrophages have been found in ad‐
vanced atherogenic lesions, such as instable plaques, respect to wild-type mice.
Intriguingly in double knockout mice (CHOP and ApoE-deficient) the rupture of athero‐
sclerotic plaques was significantly reduced despite their high-cholesterol diet [113]. Indeed
also in primary cultured macrophages free cholesterol accumulated in the ER and stimulat‐
ed apoptosis in a CHOP-dependent pathway, so CHOP probably contributed in vivo and in
vitro to instability of plaques due to macrophage cell death.
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It is emerging that, in crucial artery wall sites, the IRE1 branch of the canonical UPR mecha‐
nism and its downstream CHOP signaling are activated also by various factors like distur‐
bed blood flow and hypertension [19,114,115] and modified LDL.
High level of XBP1 splicing was detected in atherosclerosis prone areas, and in a mouse iso‐
graft model mimicking XBP1 overexpression, peculiar signs of atherogenic damage have
been detected, like neointima formation and monocytes infiltration [116].
In particular in the endothelium multiple UPR pathways are activated by phospholipolized
LDL that stimulate ER stress associated to cytoskeleton stress fibers formation, inflammation
and dysregulation of calcium homeostasis, even if strictly related to the intensity and dura‐
tion of the lipidic stress [117] (Figure 3)
Figure 3. Multiple signaling triggered by lipoproteins in endothelial cells. ATF- activating transcription factors 2, 3, 4,
6; LDL- low density lipoproteins; CHOP- C/EBP homologous protein; XBP1- x-box binding protein 1; eIF2alpha- initia‐
tion factor 2 alpha; MAPK- mitogen activated protein kinase. Adapted by [117].
However not only in the initial pro-atherogenic phase but also in advanced phase, associat‐
ed to the plaque rupture, it is crucial that the endothelium maintains its integrity, so ham‐
pering the diffusion in the blood of the circulating plaque.
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In particular during this advanced step, it has been reported that increased apoptotic endo‐
thelial cells may act as a pro-coagulant and favor the increase of platelet adhesion during the
plaque erosion [118].
In human coronary arteries plaque vulnerability is associated to the expression of ER stress
proteins like CHOP and macrophage apoptosis [119,120].
Unlike clinical patients, murine animal model of atherosclerosis are unsuited for studying
plaque disruption or acute thrombosis, so they are currently studied to characterize early
atherosclerotic phases up to necrotic plaque [121].
Recently in CHOP-deficient mice mated with ApoE-/- atherosclerotic mice, it has been dem‐
onstrated a direct causal link between reduced CHOP-induced apoptosis and plaque ne‐
crosis [122]. In this double transgenic model, ER stress has different impacts on the vascular
damage, according to the lesion stage of the artery. Indeed it is possible that in an early athe‐
rogenic phase, the UPR mechanism may be protective in macrophages and smooth muscle
cells, but after persistent damage, the UPR-induced apoptosis is associated to plaque vulner‐
ability and rupture.
Besides the endothelium, also smooth muscle cells in artery wall can be susceptible to ER
stress-UPR and compromise plaque integrity by reducing the protective fibrous cap in ad‐
vanced atherosclerosis [123].
Moreover atherogenic stressors like cholesterol and homocysteine are able to up-regulate
CHOP and apoptosis in smooth muscle cells in vitro [124]. Indeed in human aortic cells the
delivery of 7-ketocholesterol, an oxysterol linked in patients to high cardiovascular risk and
atherosclerosis, activated UPR pathway up to apoptosis [125].
However unfortunately clear molecular evidences of pathways linking UPR to smooth mus‐
cle cells in atherosclerosis are still lacking. This is not true for macrophages, and the role of
UPR in macrophages apoptosis is an emerging field of investigation [91].
Remarkably in atherosclerosis dual impact of macrophages resistance to apoptosis has been
related to different stages of the disease: it may be beneficial in early lesions, where they hin‐
der inflammation, but is detrimental in advanced phases, where they contribute to a signifi‐
cant increase in the lesion size associated to elevated chemokines expression and monocytes
recruitment [126].
Furthermore it is important to point out that if inflammatory foam cells in the sub-endotheli‐
um space are cleared by active macrophages to prevent further secondary necrosis, in paral‐
lel many inflammatory pathways are activate to potentiate atherogenic damage, including
nuclear factor k-B (NFkB) and mitogen-activated protein kinase (MAPK), in particular p38-
MAPK cascade [127].
As commonly accepted, the chronic activation of the three canonical UPR pathways in the
ER, triggers different pro-apoptotic mechanisms in the vascular wall, that may be mitochon‐
dria-dependent or independent, but largely complementary and integrated [128].
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The most common death-sensors activated in the mitochondria are: 1) the stimulation of ino‐
sitol requiring protein-1 (IRE1) that can further regulate B-cell lymphoma-2 (BCL-2) family
of proteins and 2) PERK and ATF6 signals that directly induce CHOP/GADD153 protein.
Remarkably, CHOP is also involved in the activation of a mitochondria-independent mecha‐
nism of apoptosis that relies on inositol-1,4,5-triphosphate receptor (IP3R), able to trigger ab‐
normal calcium (Ca2+) flux from the ER and the death receptor Fas [129].
Although three branches may be activated by any prolonged stressful event, the timing of
each pathway can differ and persistent ER stress leads to sequential progression of IRE1,
then ATF6, finally PERK respectively. Moreover it is important to outline that each pro-
apoptotic mechanism is strictly cell-type and stimulus-specific.
IRE 1 isoforms are activated by auto-phosphorylation and trigger the splicing and transla‐
tion of mRNA transcript for a specific transcription factor, called XBP1s, that induces chap‐
erones and other molecules able to limit ER stress.
However in mammalian cells, IRE1 stimulates also another mechanism known as regulated
IRE1 dependent decay (RIDD) [130], that may directly lead to apoptosis even if this branch
is still controversial in cardiovascular diseases.
Nevertheless the major downstream effector of IRE1 signaling is the BCL-2 family of pro‐
teins, that includes both anti-apoptotic and pro-apoptotic members able to regulate the ac‐
tivity of ER and mitochondria [131].
In human and mice anti-apoptotic domains are called Bcl-2 and Bcl-XL, while the most well
characterized pro-apoptotic are Bcl2-associated x protein (BAX) and Bcl2-homologous an‐
tagonist (BAK) proteins. When these last two members become activated in the mitochon‐
dria, release cytochrome c and other death factors that may amplify the caspases cascade up
to overt cell death. Despite in vitro observations on IRE1 signaling, actually there is not yet in
vivo evidence for apoptosis along this pathway [132].
Remarkably CHOP signaling is common also to PERK and ATF6 pathways in the ER stress
response, where it may act like in the IRE1, even if there is the possibility to by-pass the mi‐
tochondria and to stimulate calcium flux, working on the ER calcium channel called inosi‐
tol-1, 4, 5-triphosphate or IP3R [133].
Many recent studies point to the apoptotic mechanism driven by calcium release from the
ER lumen, able to stimulate the calcium-sensing enzyme called calcium/calmodulin-depend‐
ent protein kinase, CaMK II, which in turn regulates other apoptotic pathways, like FAS ac‐
tivation but also caspase 12 [134,135].
In advanced atherosclerosis, the level of ER stress-CHOP expression in macrophages is very
high despite the presence of TRLs ligands and the activation of TRIF-signaling. A crucial
concept in the regulation of macrophage apoptosis in atherosclerosis is called “the two-hit
concept”, that consists in the eventuality of a milder ER stress in vivo respect to in vitro. So
different cumulative sub-apoptotic stimuli may lead to a synergic more effective response in
the artery vessel, and in particular because generally TLRs act as a second pro-apoptotic
stimuli. If this eventuality is lost as evident in advanced ruptured plaque and related throm‐
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bosis, it may be due to an inability to resist to PERK and eIF2alpha signaling and to reduce
downstream ATF4-CHOP associated apoptosis in vivo as recently hypothesized [136].
In Figure 4 we resumed complex relationships between ER signaling and apoptosis in athe‐
rogenesis.
Figure 4. Different ER signals leading to successful apoptosis. IP3R- inositol -1,4, 5,-triphosphate receptor; PERK- pro‐
tein kinase-like ER kinase; ATF6- activating transcription factor 6; IRE1- inositol requiring protein1; BCL2- B cell lympho‐
ma/leukemia 2; Bak- Bcl2-homologous antagonist; Bax- Bcl2-associated x protein; RIDD- regulated IRE1-dependent
decay; CaMK II- calcium/calmodulin-dependent protein kinase; FAS- tumor necrosis factor receptor superfamily mem‐
ber 6; CHOP- C/EBP homologous protein; BH3- homology domain. Adapted by [107].
5. ER stress as a therapeutic target in atherosclerosis and metabolic
diseases
In metabolic diseases such as atherosclerosis, hypertension, diabetes and related cardiovas‐
cular complications, improved understanding of ER stress pathways and their relationship
with inflammation and apoptosis represents the basis on which to try novel drugs, to test
therapeutic interventions and to identify targets for different therapeutic options.
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In cardiovascular diseases but also in the endothelial cells and cardiomyocytes in vitro, the
regulation of the UPR arms can lead to an adaptation phase and survival or to a detrimental
phase that ends into cell death.
These opposite effects, considered as “the double-edged sword”, are an important issue for
vascular biology, even if the molecular mechanisms that differentially regulate survival or
cell death are yet to be clarified [137,138].
Anyway, it is possible to resume ER-regulatory interventions into two types: 1) one directly
targeting ER stress-UPR by interfering with UPR branches with the use of chemical chaper‐
ones or inhibitors; 2) others indirectly targeting ER stress-UPR by regulation of related
apoptosis, autophagy, oxidative or inflammatory signaling.
It is established that diabetic retinopathy is a major complication of diabetes, associated to
inflammation and leukocyte adhesion in the endothelium of retinal vasculature, that impairs
the inner blood-retinal barrier necessary to normal visual activity [139].
Recently ER stress has been involved in the pathogenesis of this invalidating disease [140].
However when used as a preconditioning tool, it may provide therapeutic benefits.
In particular the activation of XBP1s in endothelial cells, negatively regulates IRE1-alpha
phosphorylation and suppresses inflammation. So, improving this branch of ER stress path‐
way may be useful to prevent or limit retinopathy in diabetes [141].
Furthermore emerging data on angiotensin II-induced cardiac hypertrophy in mice, have
demonstrated a direct involvement of ER stress and related markers, GRP78 and CHOP, in
cardiac remodeling and fibrosis [18].
ER chaperones represent a group of low-molecular compounds able to increase ER folding
capacity and alleviate the accumulation of dysfunctional proteins, so maintaining ER ho‐
meostasis [142]. Different chaperones like 4-phenyl butyrate (PBA) and taurine-conjugated
deoxycholic acid (TUDCA) have been successfully tested in vivo in different murine models
of atherosclerosis, diabetes and leptin resistance where ER stress was attenuated [143].
Moreover PBA and TUDCA, have been successfully tested against endothelium-dependent
relaxation and oxidative damage in the aorta and mesenteric artery in hypertensive mice
[19]. Indeed ER signaling might represent a potential target to reverse hypertension-induced
vascular and cardiac dysfunctions.
In particular ER stress was linked also to oxidative damage, due to abnormal calcium flux
from the ER driven by protein misfolding and its uptake into the mitochondria where calci‐
um disrupted the electron transport chain [144]. Nevertheless further studies are required to
elucidate how these two mechanisms can activate each other [145].
In a mouse model of type 2 diabetes chemical chaperones increased insulin sensitivity acting
by antioxidant properties, this finding is particularly interesting because ER stress may also
induce insulin-resistance [146,147].
A recent study performed in transgenic ApoE-/- mice, fed a Western diet, has supported the
protective role of hydrogen sulfide, a product generated from L-cysteine catalyzed by cysta‐
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thionine-L-lyase in the cardiovascular system, as an effective anti-atherosclerotic compound.
Indeed it reduces oxidative damage in the aorta but also potentiates the adaptive beneficial
role of ER signaling by increasing GRP78 expression in the intima layer. This effect might be
related to the reduction of plasma level of LDL and lipids deposition in the aorta [148].
Furthermore up-regulation of T-cadherin has emerged as an effective tool that limits the
progression of atherosclerotic lesions in endothelial cells in vitro. This molecule is a glycosyl‐
phosphatidylinositol-anchored element belonging to the cadherin family, that colocalizes
with GRP78 on the plasma membrane [149]. Its over-expression or silencing by genetic ma‐
nipulations selectively attenuates or amplifies the PERK branch of the UPR cascade obtained
by ER stressors like homocysteine, thapsigargin and brefeldin A, so influencing apoptosis
[150]. Indeed T-cadherin up-regulation is able to directly limit the phosphorylation of the
eukaryotic translation initiation factor 2 alpha (phospho-eIF2alpha) and CHOP-driven cell
death, even if how it communicates with ER-stress machinery in vitro is not yet known.
Salubrinal is another chemical chaperone that modulates the dephosphorylation of eIF2alpha,
so reducing abnormal protein load on the ER and prolonged UPR, and it has been demonstrat‐
ed to limit ischemia-reperfusion damage in the mice brain [151]. Despite some promising re‐
ports, it is important to consider that there are different commercial preparations of the drug
providing different level of protection, so the real efficacy is currently debated.
Finally among ER-resident chemical chaperones oxygen-regulated protein150 (ORP150), a
150 kDa oxygen-regulated protein, has been implicated not only in reducing apoptosis dur‐
ing oxidative damage but also in preventing ox-LDLs induced ER stress in transfected vas‐
cular endothelial cells. In particular, by immune-precipitation assay it has been
demonstrated that ORP150 is bound to three ER stress sensors IRE1alpha, PERK and ATF6
so maintaining them in an inactive status and contributing to delay UPR activation. Further‐
more ORP150 and IRE1alpha were also linked in situ in atherosclerotic lesions from human
carotid plaque, but no ORP150-IRE1 alpha association was detected in normal human mam‐
mary artery [152].
A growing body of evidence indicates that LDLs, modified by oxidation, enzymatic attack,
glycation and aggregation in ox-LDL, trigger local vascular inflammation and toxic events
implicated in atherosclerosis, but in contrast high density lipoproteins (HDLs) have anti-
atherogenic properties that have been linked to reduced ER stress and autophagy [153].
In endothelial cells in vitro HDLs pretreatment was able to prevent detrimental UPR path‐
ways inhibiting IRE1 alpha activation and phosphorylation in the PERK arm and the nucle‐
ar translocation of ATF6 that triggered the pro-apoptotic CHOP signaling. All these
mechanisms were stimulated by prolonged ER stress induced by ox-LDLs that in parallel ac‐
tivated also autophagy then overwhelmed by apoptosis if the vascular stress lasted too
much. However, calcium deregulation was a common upstream signal for two parallel path‐
ways in this in vitro model, where ER stress-UPR but also autophagy are involved. Indeed
HDLs were able to prevent the increase in autophagic markers like LC3-II and beclin-1 in
the endothelial cells that, silenced for beclin 1 and then stimulated by toxic ox-LDLs, dis‐
played less ability to be recognized by macrophages.
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Remarkably, even if autophagy is not involved in apoptosis, probably contributes like a ben‐
eficial “eat-me” signal on the cell surface by exposing phosphatydylserine, necessary to the
clearance by efferocytosis of apoptotic cells [154] (Figure 5). All these important findings
suggest a potential efficacy for HDLs-based therapeutic opportunities in atherosclerosis.
Figure 5. Beneficial role of high density lipoproteins upstream ER stress and autophagy in endothelial cells. HDL- high
density lipoprotein; LDL: low density lipoprotein; ox-LDL- oxidized lipoproteins; LC3-II- microtubule-associated pro‐
tein1 light chain 3; CHOP- C/EBP homologous protein; JNK- c-Jun N-terminal kinase. Adapted from [154].
Recently an interesting study reported the peculiar expression on endothelial cells and macro‐
phages of a novel GRP78-interacting protein induced by ER stress, called Gipie [155]. Gipie be‐
longs to the Girdin family protein and is localized in the ER and Golgi apparatus in the
endothelial cell lines (human umbilical vein endothelial cell-HUVEC and human coronary ar‐
tery endothelial cells-HCAEC), but not in epithelial or mesenchymal cells in vitro. The transfec‐
tion of Gipie into HUVEC cells exposed to ER inducer thapsigargin, a specific blocker of ER
calcium ATP-ase pumps, was able to decrease CHOP expression and apoptosis.
Moreover the same protection was demonstrated by Gipie’s over-expression in rat carotid
artery endothelial cells after baloon injury, a well-known in vivo model of endothelial dam‐
age and restenosis. Finally also in adult P65 mice aorta, Gipie was superimposed with
GRP78 in atheroprone sites like the inner curvature of the aortic arch, but not in the outer
curvature or in the ascending aorta, less sensitive to hemodynamic stress. By interaction
with GRP78, Gipie modulates IRE1/JNK signaling and CHOP expression, so reducing apop‐
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tosis, even if the detailed mechanism by which it regulates GRP78/IRE1 activation is still un‐
known. Anyway even if more studies on transgenic Gipie-deficient animals will improve
the understanding of the proper function in circulatory system, Gipie may be considered a
reliable therapeutic target in atherosclerosis yet.
6. Conclusions
Actually the pivotal role of ER stress response in atherosclerosis and cardiovascular diseases
is widely accepted. Nevertheless it remains much work to do in particular to discover the
multiple relationship between different integrated pathways associated to ER signaling and
to maintain the best ER stress modulation in the endothelium and vascular wall. Indeed it is
important to point out that in biology the UPR is considered a surviving mechanism, so its
complete deregulation may not be useful but dangerous. However additional experimental
studies are required to help identify novel therapies to restore proper ER homeostasis but in
particular, those to stabilize the minority of dangerous plaques associated with acute cardio‐
vascular damage.
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